Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.04T, Eli Lilly(LLY) trades at $1,105.98. The stock has a price-to-earnings ratio of 39.54 and currently yields dividends of 0.59%.
On 2026-06-22, Eli Lilly(LLY) stock moved within a range of $1,093.15 to $1,119.00. With shares now at $1,105.98, the stock is trading +1.2% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 3.01M, compared to an average daily volume of 3.26M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
Centessa (CNTA) which entered into a definitive agreement relating to its proposed acquisition by Eli Lilly (LLY), through a wholly owned subsidiary, announced...
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today . Lilly secured f...
Berenberg analyst Kerry Holford raised the firm’s price target on Eli Lilly (LLY) to $1,135 from $1,050 and keeps a Hold rating on the shares. Unlock powerful...
Analyst ratings
84%
of 32 ratingsMore LLY News
...
Wall Street brokerage Cantor Fitzgerald is pounding the table on Eli Lilly’s (LLY) stock as we head into second-quarter earnings season. Unlock powerful invest...
Eli Lilly (NYSE:LLY) announced a new research and collaboration agreement with BioArctic AB to develop a neurodegeneration therapy using BioArctic's BrainTransp...
The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026 By Marc Guberti Published Jun 21, 4:17PM EDT Quick Read XLV sits at $149, down...
Key Points Eli Lilly is a market darling because it is a leader in the GLP-1 weight-loss market. Pfizer hasn't even entered the GLP-1 race yet, which is one r...
Key Points Eli Lilly has been buying up many small biotechs recently as it navigates its next steps. The latest deals could open up opportunities for new ther...
Key Points Vertex Pharmaceuticals and Eli Lilly are both going after the non-opioid pain management market. Vertex Pharmaceuticals has a lead, but both drugma...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.